Inhibin: definition and nomenclature, including related substancesBURGER, H. G; IGARASHI, M.Molecular endocrinology (Baltimore, Md.). 1988, Vol 2, Num 4, issn 0888-8809, 391Article

DEGRADATION OF MELANOTROPIN INHIBITING FACTOR BY BRAINHUI KS; CHENG KP; WONG KH et al.1980; J. NEUROCHEM.; GBR; DA. 1980; VOL. 35; NO 2; PP. 471-478; BIBL. 30 REF.Article

SYNTHESIS OF ANALOGUES OF THE MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR CONTAINING 2-OXOIMIDAZOLIDINE-1-CARBOXYLIC ACIDKASAFIREK E; KREJCI I; FELT V et al.1980; COLLECT. CZECH. CHEM. COMMUN.; ISSN 0010-0765; CSK; DA. 1980; VOL. 45; NO 1; PP. 294-297; BIBL. 18 REF.Article

Improvement in major depression after low subcutaneous doses of MIF-1EHRENSING, R. H; KASTIN, A. J; WURZLOW, G. F et al.Journal of affective disorders. 1994, Vol 31, Num 4, pp 227-233, issn 0165-0327Article

ASSAYS OF HYPOTHALAMIC RELEASING AND INHIBITING HORMONES.ARIMURA A; SCHALLY AV.1975; RES. METHODS NEUROCHEM.; G.B.; DA. 1975; VOL. 3; PP. 369-393; BIBL. 3 P.Article

HYPOTHALAMUS AS AN ENDOCRINE ORGAN. IBESSER GM.1974; BRIT. MED. J.; G.B.; DA. 1974; NO 5930; PP. 560-564; BIBL. 40REF.Article

Immune-neuroendocrine interactions during aging: age-dependent thyrotropin-inhibiting activity of thymosin peptidesGOYA, R. G; TAKAHASHI, S; QUIGLEY, K. L et al.Mechanisms of ageing and development. 1987, Vol 41, Num 3, pp 219-227, issn 0047-6374Article

HYPOTHALAMIC HORMONESREICHLIN S; SAPERSTEIN R; JACKSON IMD et al.1976; ANNU. REV. PHYSIOL.; U.S.A.; DA. 1976; VOL. 38; PP. 389-424; BIBL. 12 P. 1/2Article

Saturable transport of peptides across the blood-brain barrierBANKS, W. A; KASTIN, A. J.Life sciences (1973). 1987, Vol 41, Num 11, pp 1319-1338, issn 0024-3205Article

Rapid clinical effectiveness of MIF-I in the treatment of major depressive illnessVAN DER VELDE, C. D.Peptides (New York, NY. 1980). 1983, Vol 4, Num 3, pp 297-300, issn 0196-9781Article

THEORETICAL STUDIES ON PRO-LEU-GLY-NH₂ CONFORMATION.SUNGZONG KANG; WALTER R.1976; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1976; VOL. 73; NO 4; PP. 1203-1206; BIBL. 17 REF.Article

PURIFICATION OF A PROLACTIN INHIBITING HORMONE AND THE REVEALING OF HORMONE D-GHIH WHICH INHIBITS THE RELEASE OF GROWTH HORMONEGREIBROKK T; CURRIE BL; JOHANSSON KNG et al.1974; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1974; VOL. 59; NO 2; PP. 704-709; BIBL. 19REF.Article

ELECTRON IMPACT AND METHANE, ISOBUTANE AND AMMONIA CHEMICAL IONIZATION MASS SPECTRA OF PEPTIDE AMIDES RELATED TO MELANOSTATIN (PRO-LEU-GLY-NH₂)BJORKMAN S.1982; BIOMEDICAL MASS SPECTROMETRY; ISSN 0306-042X; GBR; DA. 1982; VOL. 9; NO 8; PP. 315-322; BIBL. 25 REF.Article

NEUROPHARMACOLOGIC CONTROL OF NEUROENDOCRINE FUNCTION IN MAN = CONTROLE NEUROPHARMACOLOGIQUE DE LA FONCTION NEUROENDOCRINIENNE CHEZ L'HOMMEFROHMAN LA; STACHURA ME.1975; METABOLISM; U.S.A.; DA. 1975; VOL. 24; NO 2; PP. 211-234; BIBL. 6P.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

CONFORMATIONAL ENERGY ANALYSIS OF MELANOSTATINZIMMERMAN SS; BAUM R; SCHERAGA HA et al.1982; INT. J. PEPT. PROTEIN. RES.; ISSN 0367-8377; DNK; DA. 1982; VOL. 19; NO 2; PP. 143-152; BIBL. 33 REF.Article

LASER RAMAN STUDIES ON THE CONFORMATION OF PRO-LEU-GLY-NH₂HSEU TH; CHANG H.1980; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1980; VOL. 624; NO 2; PP. 340-345; BIBL. 16 REF.Article

PEPTIDE HORMONES OF THE HYPOTHALAMUS AND PITUITARY. = HORMONES PEPTIDIQUES DE L'HYPOTHALAMUS ET DE L'HYPOPHYSEMEIENHOFER J.1975; ANNU. REP. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 10; PP. 202-211; BIBL. 2 P.Article

HYPOTHALAMISCHE FREISETZUNGS- UND HEMMHORMONE UND NEUROTRANSMITTER. = HORMONES HYPOTHALAMIQUES LIBERANTES ET INHIBITRICES ET NEUROTRANSMETTEURSDOCKE F.1977; DTSCHE GESUNDH.-WES.; DTSCH.; DA. 1977; VOL. 32; NO 11; PP. 485-489; ABS. RUSSE ANGL.Article

Welche Kältemittel in der Zukunft? = Which refrigerant in the future?DOÊRING, R.Die Kälte und Klimatechnik. 1990, Vol 43, Num 9, pp 472-482, issn 0343-2246, 6 p.Article

Th17 cytokines and mucosal immunityDUBIN, Patricia J; KOLLS, Jay K.Immunological reviews. 2008, Vol 226, pp 160-171, issn 0105-2896, 12 p.Article

MIF-1 and Tyr-MIF-1 augment GABA-stimulated benzodiazepine receptor bindingMILLER, L. G; KASTIN, A. J.Peptides (New York, NY. 1980). 1987, Vol 8, Num 5, pp 751-755, issn 0196-9781Article

An analog of MIF, alaptide: effect of serum prolactin, dopamine receptors and growth of rat adenohypophysisNEDVIDKOVA, J; KASAFIREK, E; NEDVIDEK, J et al.Endocrine research. 1994, Vol 20, Num 1, pp 39-46, issn 0743-5800Article

Inhibition by MIF-I of α-MSH induced increase of intraocular pressure and miosis in rabbitsMCCULLEN, R. K; PEIPFFER, R. L; JENNES, L et al.Neuropeptides (Edinburgh). 1988, Vol 12, Num 4, pp 213-217, issn 0143-4179Article

Effects of Pro-Leu-Gly-NH₂ and cyclo (Leu-Gly) on the binding of ³H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptorsDAS, S; MATWYSHYN, G. A; BHARGAVA, H. N et al.Peptides (New York, NY. 1980). 1986, Vol 7, Num 1, pp 21-25, issn 0196-9781Article